Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study

References

• Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33:1497–1499. doi:10.2337/dc09-2310
   PubMed Web of Science ®Google Scholar
• Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008;31:391–396. doi:10.2337/dc07-1152
   PubMed Web of Science ®Google Scholar
• Horlings CGC, van Engelen BGM, Allum JHJ, Bloem BR. A weak balance: the contribution of muscle weakness to postural instability and falls. Nat Clin Pract Neurol. 2008;4:504–515. doi:10.1038/ncpneuro0886
   PubMedGoogle Scholar
• Yoowannakul S, Tangvoraphonkchai K, Vongsanim S, Mohamed A, Davenport A. Differences in the prevalence of sarcopenia in haemodialysis patients: the effects of gender and ethnicity. J Hum Nutr Diet. 2018;31:689–696. doi:10.1111/jhn.2018.31.issue-5
   PubMedGoogle Scholar
• Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int. 2003;73:515–519. doi:10.1007/s00223-003-0023-7
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Landi F, Topinkova E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13:1–7. doi:10.1097/MCO.0b013e328333c1c1
   PubMed Web of Science ®Google Scholar
• Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249–256. doi:10.1016/j.jamda.2011.01.003
   PubMed Web of Science ®Google Scholar
• Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15:95–101. doi:10.1016/j.jamda.2013.11.025
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819–829. doi:10.1016/S2213-8587(14)70034-8
   PubMed Web of Science ®Google Scholar
• Leenders M, LB V, van der Hoeven L, et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc. 2013;14:585–592. doi:10.1016/j.jamda.2013.02.006
   PubMed Web of Science ®Google Scholar
• Lee JSW, Auyeung TW, Leung J, Kwok T, Leung PC, Woo J. Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass. J Nutr Health Aging. 2011;15:857–862. doi:10.1007/s12603-011-0134-1
   PubMedGoogle Scholar
• Calvani R, Joseph AM, Adhihetty PJ, et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem. 2013;394:393–414. doi:10.1515/hsz-2012-0247
   PubMed Web of Science ®Google Scholar
• Kalyani RR, Metter EJ, Egan J, Golden SH, Ferrucci L. Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care. 2015;38:82–90. doi:10.2337/dc14-1166
   PubMedGoogle Scholar
• Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006;55:1813–1818. doi:10.2337/db05-1183
   PubMed Web of Science ®Google Scholar
• Cetrone M, Mele A, Tricarico D. Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II. Curr Diabetes Rev. 2014;10:231–237. doi:10.2174/1573399810666140918121022
   PubMedGoogle Scholar
• Lipsky BA, Weigelt JA, Sun X, Johannes RS, Derby KG, Tabak YP. Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care. 2011;34:1695–1700. doi:10.2337/dc11-0331
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Selvarajah D. Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2012;28 Suppl 1:8–14. doi:10.1002/dmrr.2239
   PubMed Web of Science ®Google Scholar
• Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles-a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia. 2009;52:1182–1191. doi:10.1007/s00125-009-1320-0
   PubMedGoogle Scholar
• Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle strength in type 2 diabetes. Diabetes. 2004;53:1543–1548. doi:10.2337/diabetes.53.6.1543
   PubMed Web of Science ®Google Scholar
• Allen MD, Choi IH, Kimpinski K, Doherty TJ, Rice CL. Motor unit loss and weakness in association with diabetic neuropathy in humans. Muscle Nerve. 2013;48:298–300. doi:10.1002/mus.23792
   PubMedGoogle Scholar
• Andreassen CS, Jakobsen J, Andersen H. Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes. 2006;55:806–812. doi:10.2337/diabetes.55.03.06.db05-1237
   PubMed Web of Science ®Google Scholar
• Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956–962. doi:10.2337/diacare.28.4.956
   PubMed Web of Science ®Google Scholar
• Ramj N, Toth C, Kennedy J, Zochodne DW. Does diabetes mellitus target motor neurons? Neurobiol Dis. 2007;26:301–311. doi:10.1016/j.nbd.2006.11.016
   PubMedGoogle Scholar
• Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41:384–397. doi:10.1007/s12020-012-9619-x
   PubMed Web of Science ®Google Scholar
• Dinh T, Tecilazich F, Kafanas A, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012;61:2937–2947. doi:10.2337/db12-0227
   PubMed Web of Science ®Google Scholar
• Cheng QF, Hu JB, Yang P, et al. Sarcopenia is independently associated with diabetic foot disease. Sci Rep. 2017;7.
   Google Scholar
• Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–763. doi:10.1093/oxfordjournals.aje.a009520
   PubMed Web of Science ®Google Scholar
• American Diabetes A. Standards of medical care in diabetes–2012. Diabetes Care. 2012;35 Suppl 1:S11–S63.
   PubMedGoogle Scholar
• Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154. doi:10.1007/BF00400697
   PubMed Web of Science ®Google Scholar
• van Dieren S, Beulens JWJ, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17:S3–S8. doi:10.1097/01.hjr.0000368191.86614.5a
   PubMed Web of Science ®Google Scholar
• Andersen H, Stalberg E, Gjerstad MD, Jakobsen J. Association of muscle strength and electrophysiological measures of reinnervation in diabetic neuropathy. Muscle Nerve. 1998;21:1647–1654. doi:10.1002/(SICI)1097-4598(199812)21:12<1647::AID-MUS4>3.0.CO;2-D
   PubMedGoogle Scholar
• Allen MD, Kimpinski K, Doherty TJ, Rice CL. Length dependent loss of motor axons and altered motor unit properties in human diabetic polyneuropathy. Clin Neurophysiol. 2014;125:836–843. doi:10.1016/j.clinph.2013.09.037
   PubMedGoogle Scholar
• Hansen S, Ballantyne JP. Axonal dysfunction in the neuropathy of diabetes mellitus: a quantitative electrophysiological study. J Neurol Neurosurg Psychiatry. 1977;40:555–564. doi:10.1136/jnnp.40.6.555
   PubMedGoogle Scholar
• Allen MD, Major B, Kimpinski K, Doherty TJ, Rice CL. Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy. J Appl Physiol (1985). 2014;116:545–552. doi:10.1152/japplphysiol.01139.2013
   PubMedGoogle Scholar
• Hilton TN, Tuttle LJ, Bohnert KL, Mueller MJ, Sinacore DR. Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther. 2008;88:1336–1344. doi:10.2522/ptj.20080079
   PubMed Web of Science ®Google Scholar
• Yasemin O, Seydahmet A, Ozcan K. Relationship between diabetic neuropathy and sarcopenia. Prim Care Diabetes. 2019;13:521–528. doi:10.1016/j.pcd.2019.04.007
   PubMedGoogle Scholar
• Chiu CY, Yang RS, Sheu ML, et al. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway. J Pathol. 2016;238:470–482. doi:10.1002/path.4674
   PubMedGoogle Scholar
• O’Neill ED, Wilding JPH, Kahn CR, et al. Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation. Age. 2010;32:209–222. doi:10.1007/s11357-009-9125-0
   PubMedGoogle Scholar
• Andersen H, Gjerstad MD, Jakobsen J. Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care. 2004;27:2382–2385. doi:10.2337/diacare.27.10.2382
   PubMedGoogle Scholar
• Andersen H, Poulsen PL, Mogensen CE, Jakobsen J. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications. Diabetes. 1996;45:440–445. doi:10.2337/diab.45.4.440
   PubMed Web of Science ®Google Scholar